CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $6,592,000 | +251.9% | 80,000 | +300.0% | 1.18% | +125.4% |
Q2 2017 | $1,873,000 | -27.1% | 20,000 | -50.4% | 0.52% | -14.0% |
Q1 2017 | $2,570,000 | +144.8% | 40,361 | +34.5% | 0.61% | +21.3% |
Q4 2015 | $1,050,000 | -23.9% | 30,000 | +100.0% | 0.50% | -37.1% |
Q3 2015 | $1,379,000 | – | 15,000 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |